Skip to main content

BIOVIA Biologics

Dassault Systemes BIOVIA (formerly Accelrys) has launched BIOVIA Biologics, a comprehensive data management and workflow solution that supports the discovery, optimization, and development of biotherapeutic candidates.

The release includes tools that help scientists manage, process, and understand high-volume candidate antibody sequence and cell line data; assess developabilty early, and customize workflows. It also supports sharing data and analysis results and reporting and offers cloud-based deployment options.  

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.